The Most Common Mistakes When Using Oxygen Therapy or a Hyperbaric Chamber

In Summary

Oxygen is essential for aerobic metabolism. In the mitochondrial electron transport chain, it acts as the final electron acceptor and enables efficient ATP production. This does not mean, however, that oxygen is itself “energy” or that a higher oxygen concentration automatically leads to greater cellular energy production.

If oxygen availability is not the limiting factor, simply increasing the amount of available oxygen may not provide an additional energetic benefit to a healthy normoxaemic person. At higher partial pressures and with sufficiently long or repeated exposure, oxygen also becomes a highly active biological stimulus and may contribute to oxygen toxicity.

This is why all “oxygen technologies” should not be treated as one category. Breathing supplemental oxygen at normal atmospheric pressure, medical oxygen therapy, hyperbaric exposure and clinical hyperbaric oxygen therapy – HBOT – are not the same intervention. Oxygen concentration, ambient pressure, oxygen partial pressure, route of delivery, intended use, quality of evidence and safety requirements all differ.

Within Oxygen Systems™, it is therefore not enough to ask:

Does oxygen work?

The more precise question is:

In what form, at what pressure, at what concentration, for how long, for whom, for what purpose and according to which protocol is it being used?

A failure to distinguish between these variables is behind many of the most common mistakes in oxygen therapy and hyperbaric chamber use.

Mistake 1: Failing to Distinguish an Oxygen Concentrator from Hyperbaric Oxygen Therapy

One of the most common misunderstandings is the idea that breathing oxygen from a concentrator and spending time in a hyperbaric chamber are simply two different intensities of the same therapy.

They are not.

An oxygen concentrator draws in ambient air and uses separation technology to increase the oxygen concentration in the output gas. The user then breathes gas with a higher oxygen concentration at approximately normal atmospheric pressure. This is therefore a form of normobaric supplemental oxygen.

In medicine, supplemental oxygen is used primarily when the body cannot maintain adequate oxygenation or when there is another specific clinical reason for oxygen administration. An oxygen concentrator should therefore not automatically be viewed as a general wellness device that provides a healthy person with “more energy”.

A hyperbaric environment changes another fundamental variable: ambient pressure.

As pressure increases, the partial pressure of inhaled oxygen rises. According to Henry’s law, this can increase the amount of oxygen physically dissolved in plasma and other body fluids, in addition to the oxygen carried by haemoglobin.

This is one of the fundamental differences between normobaric oxygen administration and hyperbaric oxygen therapy.

An oxygen concentrator and a hyperbaric chamber are therefore not simply “weaker and stronger versions” of the same thing. They represent different forms of exposure with different physical principles, indications and safety considerations.

Mistake 2: Assuming That Every Hyperbaric Chamber Provides Clinical HBOT

The word hyperbaric means that a person is in an environment where pressure is higher than normal atmospheric pressure. The term alone does not tell us what pressure the system reaches, what gas the person breathes, what oxygen concentration is actually delivered or whether the protocol is supported by clinical evidence.

This distinction is critical.

The Undersea and Hyperbaric Medical Society – UHMS – distinguishes hyperbaric exposure itself from medically established HBOT protocols. Clinically supported hyperbaric oxygen treatments are generally delivered at substantially higher oxygen partial pressures, and evidence-based protocols commonly operate at approximately 1.9–3.0 ATA.

Exposures below approximately 1.5 ATA are often described as mild hyperbaric oxygen therapy – mHBOT. UHMS does not consider these lower-pressure approaches established treatments for recognised medical indications.

That does not mean a low-pressure chamber “does nothing”. It means something more precise: clinical outcomes demonstrated with medical HBOT cannot automatically be transferred to devices operating at substantially lower pressures or with different oxygen delivery conditions.

When comparing hyperbaric systems, relevant factors therefore include operating pressure in ATA, pressure-vessel design, pressure stability, oxygen-delivery method, actual inspired oxygen concentration, air quality, safety architecture, certification, monitoring, materials, service and the intended operating protocol.

Price alone tells us very little without this context.

Nor is it correct to assume that every soft chamber is poor quality or that every hard-shell chamber is necessarily superior. What matters is the specific device, what it is designed to do and what evidence exists for that use.

Mistake 3: Expecting an Immediate Result or Automatically Copying Clinical HBOT “Series”

A single hyperbaric session may feel pleasant. Some people may describe a sense of calm, lightness, freshness or another subjective change afterwards.

That experience is not proof of a deep biological effect, nor does it confirm a therapeutic outcome.

The opposite mistake is equally important: assuming that because clinical HBOT for a particular medical indication uses a series of repeated sessions, the same logic automatically applies to a healthy person using a different chamber for general recovery.

In clinical hyperbaric medicine, the number, pressure, duration and frequency of treatments depend on the specific indication. Some conditions may involve many treatment sessions, while acute conditions can follow a very different protocol.

There is no universal rule such as:

“Everyone needs 10, 20 or 40 chamber sessions before a regenerative effect appears.”

Communication around wellness or home hyperbaric use should be even more cautious, because the quality of evidence for general recovery in healthy individuals is not equivalent to the evidence supporting recognised medical indications for HBOT.

The correct question is therefore not how many sessions a person “needs”.

It is:

What specific outcome are we trying to influence, what type of exposure are we using, and is there a reasonable evidence-based basis for expecting that outcome?

Mistake 4: Ignoring Health Status and Contraindications

A hyperbaric environment is not simply a comfortable wellness space. Changes in ambient pressure affect every gas-containing cavity in the body, and elevated oxygen partial pressure represents a genuine physiological exposure.

For HBOT, an untreated pneumothorax is regarded as the principal absolute contraindication. Increasing and subsequently reducing ambient pressure in the presence of trapped pleural gas can create serious risk.

Many other conditions are relative contraindications or require individual assessment. These may include certain forms of COPD associated with CO₂ retention, asthma or pulmonary bullae with a risk of air trapping, a history of spontaneous pneumothorax, acute upper respiratory infection, Eustachian tube dysfunction, certain implanted devices, severe claustrophobia, fever, increased seizure susceptibility and selected drug or oncology regimens.

Pregnancy should not be reduced to a simple yes-or-no rule either. It requires individual medical assessment, and in certain urgent situations – for example severe carbon monoxide poisoning – HBOT may be considered despite pregnancy.

This is why a high-quality hyperbaric programme does not begin when the chamber door closes.

It begins with screening the person who is about to enter it.

In medical HBOT, suitability should be determined by a qualified healthcare team. Even in wellness or home hyperbaric use, health status should be known, and relevant conditions or uncertainties should be discussed with a physician.

Mistake 5: Waiting Until the Ears Hurt Before Equalising Pressure

Middle-ear barotrauma is among the most common complications of hyperbaric exposure.

The mechanism is straightforward. As ambient pressure rises, pressure in the middle ear must follow the increasing chamber pressure. The Eustachian tube enables this equalisation. If pressure is not equalised quickly enough, a pressure gradient develops across the tympanic membrane and the person may begin to feel pressure, discomfort or pain.

The mistake is waiting until pain becomes pronounced.

Pressure should be equalised early, gently and repeatedly during compression. Swallowing, yawning, jaw movement or a careful equalisation technique may help. The Valsalva manoeuvre should not be performed aggressively.

If pressure cannot be equalised, the correct response is not to “push through”.

Compression should be slowed or temporarily stopped and, where appropriate, pressure may need to be reduced slightly. If the problem persists, the exposure should be discontinued.

Ear pain is not evidence that pressure is “working”.

It is a warning that the physical conditions exceed the middle ear’s ability to equalise pressure safely.

Mistake 6: Using the Chamber with a Cold, Blocked Sinuses or Acute Illness

What may be only an inconvenient cold in everyday life can become a significantly greater problem in a pressure chamber.

Swollen mucous membranes, nasal obstruction, sinus infection or Eustachian tube dysfunction can restrict the movement of air between body cavities and the surrounding environment. During compression or decompression, this can increase the risk of pain and barotrauma affecting the middle ear or paranasal sinuses.

A similar issue may arise with active ear pain or following certain ENT procedures.

An acute infection accompanied by fever creates an additional reason for caution: elevated body temperature may lower the threshold for CNS oxygen toxicity.

Entering the chamber despite an inability to breathe freely through the nose or equalise pressure is therefore not a sign of discipline.

A high-quality protocol also includes the ability to say:

Not today.

Mistake 7: Underestimating Fire Safety

Oxygen itself does not burn.

It does, however, strongly support combustion. Materials that are relatively difficult to ignite or burn slowly under normal conditions may behave much more aggressively in an oxygen-enriched environment.

Hyperbaric systems also combine a pressurised environment with technical equipment, materials, electrostatic phenomena and, in some configurations, high oxygen concentrations. Fire safety is therefore one of the fundamental requirements of responsible operation.

In August 2025, the U.S. Food and Drug Administration issued a specific safety communication following reports of serious injuries and deaths associated with fires involving hyperbaric devices. The FDA emphasised adherence to manufacturer instructions, regular maintenance, grounding, staff training, user monitoring and strict control over objects and materials entering the chamber.

The design of the system also matters. Not every chamber has the same internal atmosphere. In some multiplace chambers, the chamber is pressurised with air while the patient breathes oxygen through a mask or hood. Some monoplace systems may operate with a substantially oxygen-enriched internal environment.

There is therefore no single universal list of objects that applies to every hyperbaric chamber.

Electronics, batteries, power banks, unsuitable synthetic fabrics, oils, greasy products, cosmetics and other potentially hazardous items must be evaluated according to the exact rules of the particular system.

In hyperbaric technology, fire-safety discipline is not an administrative detail.

It is part of the safety architecture of the device itself.

Mistake 8: Assuming That Higher Pressure, More Oxygen and Longer Exposure Are Automatically Better

With oxygen, it is especially important to abandon the linear idea that “more is better”.

Oxygen is essential for life, but at high partial pressures it is not biologically neutral. Increased hyperoxic exposure increases the production of reactive oxygen species. The body has extensive antioxidant defence systems, but these systems have limits.

When the intensity or cumulative dose of hyperoxia exceeds the organism’s adaptive capacity, oxygen toxicity can occur.

Acute CNS oxygen toxicity may involve neurological symptoms and, in rare cases, a generalised seizure. The risk depends on oxygen partial pressure, exposure duration and individual susceptibility. Clinical hyperbaric medicine therefore uses precisely defined protocols and, where appropriate, air breaks.

With prolonged or cumulatively high hyperoxic exposure, pulmonary oxygen toxicity may also become relevant.

Repeated HBOT can affect the eye as well. A recognised effect is a temporary myopic shift – a reversible reduction in distance vision associated with changes in the lens. With very extensive cumulative exposure, progression of cataract has also been described.

These mechanisms do not mean that clinical HBOT is inherently “dangerous”. When appropriately indicated and correctly administered, HBOT has well-established medical applications.

They do, however, show why the assumption

higher pressure + more oxygen + longer exposure = better result

is biologically incorrect.

With oxygen, dose matters.

Mistake 9: Neglecting the Technical Condition of the Chamber, Concentrator, Filters and Air Pathways

The quality of an oxygen system is not defined only by its maximum pressure or nominal oxygen concentration.

What matters is whether the system can deliver its intended parameters consistently, safely and reproducibly.

In an oxygen concentrator, relevant factors include filters, cleanliness of intake air, condition of the molecular sieve material, actual oxygen concentration at the outlet, flow rate, tubing and regular servicing. A concentrator that powers on and makes the expected sound does not necessarily mean that it is still delivering its original specified performance.

A hyperbaric system adds another layer of complexity: the pressure structure itself, seals, valves, pressure sensors, compressor, air-supply and exhaust pathways, oxygen-delivery method, monitoring, electrical safety, grounding, materials and fire-safety architecture.

Maintenance must follow the instructions of the specific manufacturer and the service schedule appropriate for that particular device.

Medical HBOT also involves specific requirements for equipment, personnel, monitoring and operation that cannot be replaced by routine home maintenance.

A premium oxygen system is therefore not simply a chamber with an attractive interior.

It is pressure and respiratory technology in which safety must be integrated into both design and operation.

Mistake 10: Treating Oxygen as a Universal Source of Energy or a Substitute for Basic Physiology

Oxygen is essential for mitochondrial ATP production.

That does not mean that a person with normal oxygenation follows the simple equation:

more oxygen = more energy = better recovery.

Energy production depends on the entire metabolic system: substrates, mitochondrial function, enzymes, perfusion, microcirculation, oxygen transport, hormonal and autonomic regulation, sleep, nutrition, movement and overall health status.

If oxygen availability is not the limiting factor, increasing oxygen concentration alone may not solve whatever factor is actually limiting performance or recovery.

Oxygen technology also cannot replace chronically inadequate sleep, movement, nutrition, hydration or treatment of the underlying condition responsible for symptoms.

The same principle applies within TANVEA Biological Systems™.

Oxygen Systems™ should not be presented as a technology that automatically “amplifies” Thermal, Light, Hydro or Hydrogen Systems™. Each system works with a different physical or biological input, and combinations should not be described as proven synergies unless evidence for that specific combination exists.

Systems thinking means something more precise:

the same organism responds to multiple inputs, and each of those inputs must be understood in the biological context of the person receiving it.

Not more stimuli.

Better-understood stimuli.

How to Approach Oxygen Technology Properly

The first step should not be choosing a device.

The first step should be defining why the person is considering oxygen or hyperbaric exposure in the first place.

If a person has hypoxaemia or another condition requiring supplemental oxygen, this belongs to the domain of medical oxygen therapy. In that context, an oxygen concentrator is a device used to deliver a specific treatment regimen, not a general wellness accessory.

If a recognised medical indication for HBOT exists, appropriate clinical protocols, a suitable pressure chamber, medical oxygen, qualified personnel, monitoring and professional supervision become central. UHMS recognises indications that include decompression sickness, air or gas embolism, carbon monoxide poisoning, selected difficult wounds, delayed radiation injury, certain severe infections, compromised grafts and flaps, and sudden sensorineural hearing loss.

If a person is considering a low-pressure or home hyperbaric chamber for wellness or recovery, expectations must be different. Such exposure should not be presented as equivalent to medical HBOT, and outcomes from clinical HBOT studies should not automatically be transferred to it.

Only then does technical comparison begin: pressure, chamber construction, environmental stability, oxygen-delivery method, air quality, safety systems, materials, servicing, maintenance, fire safety and actual operating conditions.

Only after these variables are understood does price become a meaningful comparison.

TANVEA Oxygen Systems™: Precision Instead of Exaggerated Claims

TANVEA has no reason to diminish the importance of oxygen.

But neither does it have any reason to exaggerate it.

Oxygen is one of the most fundamental molecules in aerobic physiology. Hyperbaric medicine is also an established medical field with specific indications, protocols and mechanisms that cannot be reduced to a marketing statement about “more oxygen for the cells”.

At the same time, evidence from clinical HBOT cannot be used as automatic support for every product that creates a mildly elevated pressure environment.

The highest TANVEA standard is therefore not to claim that oxygen solves everything.

It is to state clearly:

what the technology does, what we know about it, what we do not yet know, for whom it may make sense and where its safety boundaries begin.

That is how trust is built.

Conclusion

The most common mistakes in oxygen therapy and hyperbaric chamber use do not arise because oxygen itself is complicated.

They arise because a very simple molecule enters a highly complex physiology.

An oxygen concentrator is not a hyperbaric chamber. Hyperbaric exposure is not automatically clinical HBOT. Mild hyperbaric use cannot inherit medical claims from protocols performed at different pressures and with different oxygen doses. One session is not evidence of effectiveness, but neither is a series of sessions automatically appropriate for everyone.

Higher pressure is not automatically better. More oxygen is not automatically better. Longer exposure is not automatically better.

What matters is the indication, pressure, oxygen partial pressure, time, frequency, technology, safety and the person undergoing the exposure.

Once these variables are understood, oxygen stops being a marketing word.

It becomes a precisely defined biological and physical tool.

And that is how TANVEA Oxygen Systems™ approaches it.

---

FAQ

Is an oxygen concentrator the same as a hyperbaric chamber?

No. An oxygen concentrator increases the concentration of inhaled oxygen at approximately normal atmospheric pressure. A hyperbaric chamber also increases ambient pressure, thereby changing oxygen partial pressure and the physical conditions of oxygen transport in the body.

Does a healthy person need oxygen from a concentrator for more energy?

This should not be assumed as a general rule. Supplemental oxygen has established medical applications particularly when oxygenation is inadequate or there is another specific clinical indication. In a healthy normoxaemic person, more oxygen does not automatically mean more ATP or more energy.

Is a mild hyperbaric chamber the same as clinical HBOT?

No. Low-pressure hyperbaric exposures and evidence-based clinical HBOT protocols may differ substantially in pressure, oxygen concentration, oxygen partial pressure and quality of evidence. Outcomes from clinical HBOT cannot automatically be transferred to mild hyperbaric use.

What pressure is used in clinical HBOT?

The exact pressure depends on the indication and protocol. UHMS states that evidence-supported hyperbaric treatments are generally performed at approximately 1.9–3.0 ATA. Lower pressures should not automatically be considered equivalent to those protocols.

What is the main absolute contraindication to HBOT?

Untreated pneumothorax is regarded as the principal absolute contraindication. Many other health conditions are relative contraindications or require individual medical assessment.

What should I do if my ears begin to hurt during compression?

Compression should not be forced. Pressure should be equalised early and gently. If equalisation is not possible or pain develops, compression should be slowed or stopped and the session discontinued if necessary.

Can I use a hyperbaric chamber when I have a cold?

If the nose is blocked, the sinuses are inflamed, there is ear pain or another condition that interferes with pressure equalisation, it is sensible to postpone the exposure or discuss the situation with a qualified professional. Obstructed sinuses and Eustachian tubes increase the risk of barotrauma.

Can too much oxygen be harmful?

Yes. A sufficiently high hyperoxic dose can cause oxygen toxicity. It may affect the central nervous system, the lungs and, with repeated hyperbaric exposure, the ocular lens. Risk depends on oxygen partial pressure, exposure duration, cumulative dose and individual factors.

Is a hyperbaric chamber a fire risk?

Oxygen itself does not burn, but it strongly supports combustion. Hyperbaric systems therefore require tightly controlled materials, operating procedures, maintenance and rules governing which objects may enter the chamber according to the specific design and manufacturer instructions.

---

Scientific and Safety Foundations

Undersea and Hyperbaric Medical Society – UHMS Guidelines for Credentialing, Privileging and Supervision of Hyperbaric Oxygen Therapy in the U.S.A., rev. April 2026.
This current UHMS framework distinguishes the scientific definition of hyperbaric oxygen therapy, evidence-supported clinical hyperbaric protocols and unproven “mild hyperbaric” applications. Evidence-supported hyperbaric treatments are generally conducted at approximately 1.9–3.0 ATA.

Undersea and Hyperbaric Medical Society – Hyperbaric Oxygen Therapy Indications, 15th Edition.
Defines recognised medical indications for HBOT and emphasises the need for qualified clinical supervision, appropriate pressure technology and safe operation.

U.S. Food and Drug Administration – Follow Instructions for Safe Use of Hyperbaric Oxygen Therapy Devices, 25 August 2025.
Following reports of serious injuries and deaths associated with hyperbaric-device fires, the FDA emphasised fire-safety measures, grounding, monitoring, staff training, maintenance and strict operational controls.

Gawdi R, Yrastorza J, Cooper JS. Hyperbaric Oxygen Therapy Contraindications. StatPearls. Updated 2025.
A clinical overview of HBOT contraindications. Untreated pneumothorax is identified as an absolute contraindication, with a range of pulmonary, ENT, neurological and other conditions described as relative contraindications or situations requiring additional assessment.

Sadri RA, Cooper JS. Hyperbaric Complications. StatPearls. 2025.
A review of HBOT complications including middle-ear and sinus barotrauma, pulmonary barotrauma, oxygen toxicity, claustrophobia and temporary visual changes.

Cooper JS, Hendriksen S, Launico MV. Hyperbaric Related Myopia and Cataract Formation. StatPearls. Updated 2026.
Describes transient myopic shift during repeated HBOT and lens changes associated with high cumulative hyperoxic exposure.

Cleveland Clinic – Supplemental Oxygen Therapy. Updated 2026.
A medical overview of supplemental oxygen therapy, its indications, the use of oxygen concentrators and the risks associated with unnecessary or excessive oxygen administration.

---

TANVEA Safety Note

This article is an educational resource within TANVEA Library → SCHOOLS → OXYGEN SYSTEMS. It does not replace medical examination, diagnosis, prescription of medical oxygen therapy or professional supervision of clinical hyperbaric oxygen therapy.

In the presence of health conditions, medication use, previous pneumothorax, pulmonary disease, ear or sinus problems, recent surgery, pregnancy or other relevant medical circumstances, the suitability of hyperbaric exposure should be assessed individually.

For every hyperbaric device, follow the current manufacturer instructions, maximum operating pressure, oxygen-system requirements, fire and electrical safety rules, service intervals and permitted materials.